AI generated summary of Pubmed citation/abstract with PMID 38093494

https://pubmed.ncbi.nlm.nih.gov/38093494
The ‘Peptide for Life’ (P4L) initiative, led by the Heart Failure Association, aimed to increase the use of natriuretic peptide (NP) testing in Emergency Departments (EDs) across Western Balkan countries for the early diagnosis of heart failure. A registry of 10 centers in five countries was conducted, comparing NP adoption before and after implementing the P4L-ED study. An educational campaign and point-of-care instruments were provided to participating centers. The results showed a significant increase in NP testing in the ED from 55.9% to 80.3% before and after the P4L-ED study, respectively. Additionally, the combined use of NPs and echocardiography, as well as prescriptions for diuretics and SGLT2 inhibitors, also increased during the post-P4L-ED phase. The study suggests that increasing awareness and providing resources can improve the utilization of NPs, leading to better diagnostic accuracy and enhanced patient care.